Literature DB >> 19691259

Physical activity before and during pregnancy and duration of second stage of labor among Hispanic women.

Prasad Gawade1, Penelope Pekow, Glenn Markenson, Michael Plevyak, William Goh, Lisa Chasan-Taber.   

Abstract

OBJECTIVE: To study a possible association between physical activity and the duration of second stage of labor among Hispanic women. STUDY
DESIGN: We evaluated this relationship in the Latina Gestational Diabetes Mellitus Study, a prospective cohort of Hispanic obstetric patients. The Kaiser Physical Activity Survey was used to collect information on physical activity in prepregnancy, early pregnancy and mid-pregnancy. Duration of labor was abstracted from medical records. A total of 725 women with a singleton pregnancy and a spontaneous vaginal delivery were included, which yielded > 80% power to detect a clinically meaningful mean difference of 30 minutes.
RESULTS: The mean duration of second-stage of labor was 34.3 min (SD 42.02). After adjusting for established risk factors, no significant differences in duration of labor were observed among women according to physical activity level in prepregnancy, early pregnancy, or midpregnancy.
CONCLUSION: Findings confirm prior literature demonstrating the absence of an association between physical activity and duration of labor.

Entities:  

Mesh:

Year:  2009        PMID: 19691259

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

Review 1.  Physical activity and pregnancy: cardiovascular adaptations, recommendations and pregnancy outcomes.

Authors:  Katarina Melzer; Yves Schutz; Michel Boulvain; Bengt Kayser
Journal:  Sports Med       Date:  2010-06-01       Impact factor: 11.136

2.  Prepregnancy Body Mass Index, Gestational Weight Gain, and Odds of Cesarean Delivery in Hispanic Women.

Authors:  Megan W Harvey; Barry Braun; Karen A Ertel; Penelope S Pekow; Glenn Markenson; Lisa Chasan-Taber
Journal:  Obesity (Silver Spring)       Date:  2017-11-16       Impact factor: 5.002

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.